[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "First reported COVID reinfection", "description": "Reinfection\nFirst case of reinfection\n\nDr. Kelvin Kia Wang\n\nhttps://hub.hku.hk/cris/rp/rp01384\n\nFirst case of reinfection, 23 million COVID-19 cases\n\nJournal Clinical Infectious Diseases\n\nhttps://edition.cnn.com/2020/08/24/health/covid-19-reinfection-hong-kong-study/index.html\n\nhttps://twitter.com/cwylilian/status/1297857565385093121/photo/1\n\nNot prolonged viral shedding\n\n33-year-old man, good health\n\nImmunocompetent\n\nFirst infection\n\n3 days, cough, sore throat, fever, headache\n\nHospitalized\n\nSerum at day 10, negative for IgG\n\n26th March\n\nOropharyngeal antigen PCR diagnosis\n\n14th April\n\nDischarged asymptomatic\n\n142 days\n\n2nd infection\n\nSpain - UK \u2013 HK\n\n15th August\n\nOropharyngeal positive at HK airport\n\nHospitalised, remained asymptomatic\n\nT, 36.5 \n\nHR, 86\n\nBP, 133/94\n\nSaO2, 98 RA\n\nCRP, 8.6 mg / L\n\nSlightly raised, suggesting acute infection\n\nDeclining during hospitalisation\n\nHypokalaemia\n\nViral load progressively decreased\n\nSerum day 5 of hospitalisation, positive\n\nGenome analysis\n\nFull sequencing performed after first and second episode\n\nDifferent clade/lineage\n\nTruncation of 58 amino acids in the virus genome\n\n23 nucleotide changes\n\n13 of which non-synonymous mutations\n\n4 in the spike protein\n\nFirst strain\n\nMostly close to strains from USA or England collected in March and April\n\nSecond strain\n\nSwitzerland and England collected in July and August\n\nEvidence\n\nGenomics, phylogenetic analysis\n\n142 days, viral shedding (104 days in one pregnant woman)\n\nRaised CPR indicating acute infection\n\nPatient had recently returned from Europe with July and August strains\n\nImplications\n\nUnlikely herd immunity can eliminate SARS-CoV-2\n\nSubsequent infections likely to be milder\n\nVirus likely to go on circulating in the human population\n\nVaccine will not provide lifelong infection\n\nVaccine studies should include patients who have recovered from COVID\n\nPeople who have had COVID should be vaccinated\n\nPeople who have had COVID should continue with public health measures\n\nResidual low level of antibodies may have controlled the second infection\n\nWHO\n\nhttps://www.who.int/docs/default-source/coronaviruse/media-advisory-covid-19-virtual-press-conference-24-august-2020.pdf?sfvrsn=e22ef35e_0\n\nDr Maria Van Kerkhove\n\nI haven't read the study\n\nOur expectations, people who are infected with this virus develop an immune response \n\nPeople do develop an immune response, not completely clear yet is how strong and how long lasting\n\nSevere, mild, asymptomatic cases, develop an immune response\n\nMore than 24 million cases\n\nOn a population level\n\nLongitudinal studies, following the same individual underway\n\nInductive thinking, Bottom up\nDeductive thinking, Top down", "link": "https://www.youtube.com/watch?v=zJJ5gw2cVkA", "date_published": "2020-08-25 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Long COVID with Andrew", "description": "Thank you, Andrew, for having the courage to share your experiences and difficulties with us. Many people with be able to relate to your experience and will greatly benefit from knowing they are not alone.\n\nAndrew had an antigen test in late April (swab test - negative). This was the first possible opportunity he had to be tested - nothing else was available before then.", "link": "https://www.youtube.com/watch?v=sIqwtCx5xvE", "date_published": "2020-08-25 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Coronavirus, Death Rates Plummet", "description": "UK\nSymptom tracker\nhttps://covid.joinzoe.com/post/incidence-update-21-aug\n\nOver 4 million contributors\n\n1,265 new cases per day\n\n18, 933 symptomatic cases today\n\nData is consistent with the ONS household survey\n\nONS numbers slightly higher due to inclusion of asymptomatics\n\nSymptomatic and asymptomatic cases\n\nDown from last week\n\nLocalised outbreaks not spreading\n\nCommunity spread continues\n\nLower death rates\n\nhttps://www.theguardian.com/world/2020/aug/23/why-do-covid-fatalities-remain-low-when-infection-numbers-are-rising\n\nEurope, cases rising\n\nSevere complications and deaths remain relatively low\n\nUK ventilated patients, 3,000 down to 70\n\nInfection fatality rate\n\nIs the severity of the disease decreasing a bit?\n\nU Pittsburgh MC doctor says COVID-19 has become \u2018less prevalent\u2019 and isn\u2019t making people as sick\n\nhttps://www.pennlive.com/news/2020/06/upmc-doctor-says-covid-19-has-become-less-prevalent-and-less-severe.html\n\nDr. Donald Yealy\n\nAll signs that we have available right now show that this virus is less prevalent than it was weeks ago\n\nAmong people who test positive, the total amount of the virus the patient has is much less than in the earlier stages of the pandemic\n\nWe see all of this as evidence that COVID-19 cases are less severe than when this first started\n\nVirus mutating?\n\nhttps://www.healthline.com/health-news/is-the-new-coronavirus-getting-weaker-what-to-know\n\nTriad of infectious disease, viral evolution\n\nStudy concluded that most mutations were neutral and did not affect viral lethality\n\nFactors\n\nTesting at an earlier stage of the illness\n\nSocial distancing, face coverings, hand and surface hygiene\n\nInfection with lower viral load\n\nSummer humidity reducing infection\n\nMedical interventions more successful\n\nDexamethasone\n\nHeparin\n\nBecoming a disease of younger people\n\nHowever\n\nUS, recent spike, 20s and 30s\n\nFollowed by a spike in older people\n\nThis could happen in UK and Europe in coming few weeks\n\nUS\n\nFood and Drug Administration, emergency authorisation of convalescent plasma\n\nTemporary emergency use authorization\n\nhttps://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma\n\nhttps://www.bbc.co.uk/news/world-us-canada-53884710\n\nHealth care providers or acute care facilities, obtain COVID-19 convalescent plasma from an FDA-registered blood establishment\n\n20,000 patients reviewed, safe\n\nConvalescent plasma or hyperimmune immunoglobulin for people with COVID\u201019: a living systematic review\n\nhttps://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub2/full\n\nWe are very uncertain whether convalescent plasma;\n\nhas any effect on all\u2010cause mortality at hospital discharge\n\nprolongs time to death\n\nhas any effect on improvement of clinical symptoms at seven days\n\nSafety\n\nThere is only very low\u2010certainty evidence for safety of convalescent plasma for COVID\u201019\nAllergic or respiratory problems\nTransfusion\u2010associated dyspnoea\nTransfusion\u2010related acute lung injury", "link": "https://www.youtube.com/watch?v=cT9nfh8ZrFQ", "date_published": "2020-08-24 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]